News
CHRO
2.010
-4.74%
-0.100
Financial Report: Overview of Financial Performance and Key Metrics
Press release · 21h ago
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers CareCloud stock moved upwards by to $ during Monday's regular session. Novavax stock rose   to $ after their, Q1 earnings came out yesterday. The company's market cap stands at $ billion. Losers TransCode Therapeutics and Applied DNA Sciences also declined.
Benzinga · 3d ago
Weekly Report: what happened at CHRO last week (0506-0510)?
Weekly Report · 3d ago
Weekly Report: what happened at CHRO last week (0429-0503)?
Weekly Report · 05/06 12:56
Weekly Report: what happened at CHRO last week (0422-0426)?
Weekly Report · 04/29 13:05
Weekly Report: what happened at CHRO last week (0415-0419)?
Weekly Report · 04/22 12:45
SBFM, BPTH and INDO among pre-market losers
On the Move SBFM, BPTH and INDO among pre-market losers. Hepion Pharmaceuticals -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial. Terronera surpasses 50% construction completion.
Seeking Alpha · 04/22 12:23
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Super Micro Computer, Inc. Shares fell 13.2% to $806.00 on Friday. The company announced its third-quarter earnings date and did not provide preliminary estimates. Next.e.GO shares jumped 129% in the mid-day session. Redwoods Acquisition Corp. Shares rose 62.5% after falling around 3%.
Benzinga · 04/19 17:25
12 Health Care Stocks Moving In Friday's Pre-Market Session
Chromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. Kineta stock moved upwards by 16.62% and Erasca stock rose 13.73%. Nexalin Technology (NASDAQ:NXL) stock fell 18.4% during the day.
Benzinga · 04/19 12:08
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
The Travelers Companies, Inc. Shares dipped 8.1% to $205.03 on Wednesday. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. InVO Bioscience shares shot up 256% after the company reported a year-over-year increase in fourth-quarter revenue.
Benzinga · 04/17 17:36
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
INVO Bioscience shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The company's, Q4 earnings came out yesterday. Clene shares moved upwards by 40.8% and Galera Therapeutics shares moved up by 31.6%. Sage Therapeutic (NASDAQ:SAGE) stock decreased by 19.4%.
Benzinga · 04/17 12:08
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
INVO Bioscience stock is rocketing more than 55% alongside its Q4 earnings report. Vanda Pharmaceuticals shares are soaring over 38% on a firm acquisition proposal. VIA Optronics stock is surging more than 32% with heavy pre-market trading. Moving stocks this morning are earnings reports, acquisition plans, new drug data and more.
Investorplace · 04/17 11:33
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
Shares of INVO Bioscience, Inc. (NASDAQ:INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results. The company said quarterly revenue surged 397% year-over-year to $1,381,754. Mobile Global Esports Inc. Shares gained 36.1% on Tuesday.
Benzinga · 04/17 10:13
Financial Report Analysis: Key Metrics and Trends
Press release · 04/16 22:21
Weekly Report: what happened at CHRO last week (0408-0412)?
Weekly Report · 04/15 12:35
Chromocell CEO Issues Letter To Stockholders
Chromocell closed its IPO on February 21, 2024, raising gross proceeds of approximately $6.6 million. The company's lead compound, CC8464, shows no addictive or euphoric properties. The drug is being developed for the treatment of neuropathic pain.
Benzinga · 04/09 12:40
Weekly Report: what happened at CHRO last week (0401-0405)?
Weekly Report · 04/08 12:42
Weekly Report: what happened at CHRO last week (0325-0329)?
Weekly Report · 04/01 12:38
BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Reddit, Stoke Therapeutics
The Dow Jones Industrial Average was up 0.72% on Wednesday. Merck & Co hit record high as FDA approves therapy for rare lung condition. Reddit Inc up 46% in fifth day of trading. Netflix, Reddit, Stoke Therapeutics are among the day's top stocks.
Reuters · 03/27 17:45
iBio, ImmunityBio, Mesoblast among healthcare movers
IBio, ImmunityBio, Mesoblast among healthcare movers. S&P 500 Health Care Sector +1.04% to 1717.5. Pharmaceuticals, Biotechnology & Life Science contributes 58% to the index. IBio, immunityBio, mesoblast are among the biggest gainers.
Seeking Alpha · 03/27 14:00
More
Webull provides a variety of real-time CHRO stock news. You can receive the latest news about Chromocell Therapeutics Corporation through multiple platforms. This information may help you make smarter investment decisions.
About CHRO
Chromocell Therapeutics Corporation is a clinical-stage biotech company, which is focused on developing and commercializing therapeutics to alleviate pain. The Company's clinical focus is to selectively target the sodium ion-channel, NaV1.7, as well as other receptors in the NaV family. Its lead compound, CC8464, is designed to address both the underlying condition and mitigate the burning pain symptoms, which erythromelalgia (EM) patients experience by blocking the NaV1.7 sodium channel. CC8464 has completed Phase I study. A total of approximately 207 healthy subjects have been dosed in four Phase I studies (CC8464-1001, CC8464-1002, CC8464-1003, and 1807-CL-0102) with study treatment.